Skip to main content
Caplight Logo









PleoPharma, Inc.

PleoPharma, Inc.

Private
Phoenixville, PennsylvaniaHealthcare & Life Scienceshttps://www.pleopharma.com/

Last Round

Grant

Aug 10, 2026

Total Funding Raised

$53.5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

PleoPharma, Inc. is a clinical-stage pharmaceutical company that develops therapeutics for neuropsychiatric and substance use disorders, with a primary focus on treating cannabis use disorder and cannabis withdrawal syndrome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cannabis withdrawal syndromecannabis use disorderCWSCUDaddiction medicineclinical-stage biotechCNS therapeuticscentral nervous systemdrug developmentphase 3 clinical trialsaddiction treatmentsubstance abuse treatmentrehab techpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PleoPharma, Inc. Comparables

Compare PleoPharma, Inc. with similar companies based on industry and business-model similarity.

PleoPharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aelis Farma SA
81%
Disrupt Therapeutics
80%
Kinoxis Therapeutics
76%

PleoPharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 10, 2026
Series BOct 21, 2025
Series AJun 30, 2023

PleoPharma, Inc. Investors

Notable investors and investment history

PleoPharma, Inc. investors
InvestorRounds
National Institute on Drug AbuseGrant
MintPharma CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 10, 2026

    Raised $5.5M in seed funding.

  • Oct 21, 2025

    $36M round completed.

PleoPharma, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PleoPharma, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PleoPharma, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPhoenixville, Pennsylvania
Employee Range12
Year Founded2019
Last FundingAug 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?